The company has always contributed to sharing clinical trials data and the results to relevant researchers and patients. The company believes that sharing of successful and unsuccessful results with other researchers can help in speeding up the process of finding new therapies. It can also help in reducing duplication and the findings of one trial can benefit the future researchers.
As announced, Sanofi will provide access to data and documents related to clinical trial. This would also include Clinical Study Reports (CSR), for clinical studies sponsored by Sanofi companies conducting clinical studies in humans. Also, the company would continue submitting results for publication irrespective of their outcomes. IGMPI
